Qualitative plasma PCR (AMPLICOR CMV) vs pp65 antigenemia (AG) for monitoring active cytomegalovirus (CMV) infection and pre-emptive ganciclovir therapy after allogeneic peripheral blood stem cell transplantation (Allo-PBT).

被引：0
|
作者：
Solano, C [1 ]
Gutierrez, A [1 ]
Munoz, I [1 ]
Navarro, D [1 ]
Garcia-Clavel, B [1 ]
Teruel, I [1 ]
Gomez, C [1 ]
Gimeno, C [1 ]
Garcia-Conde, J [1 ]
机构：
[1] Univ Valencia, Hosp Clin, Valencia, Spain
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1658
引用
收藏
页码：394A / 394A
页数：1
相关论文
共 39 条
  • [21] PCR-based pre-emptive therapy of cytomegalovirus infections after allogeneic stem cell transplantation with sequential intravenous ganciclovir foscarnet and oral ganciclovir.
    Chakrabarti, S
    Collingham, K
    Pillay, D
    Milligan, DW
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 57 - 57
  • [22] Pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation guided by quantitative real time-PCR
    Banan, A.
    Ramzi, M.
    Varnik, E.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S335 - S335
  • [23] Pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation guided by quantitative real time-PCR
    de la Cruz Vicente, F.
    Gracia-Ahufinger, I.
    Perez-Romero, P.
    Aguilar Guisado, M.
    Parody Ruiz-Berdejo, R.
    Cisneros Herreros, J. M.
    Urbano-Ispizua, A.
    Espigado, I.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S229 - S229
  • [24] Results of a BSBMT phase I/II-study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following reduced intensity allogeneic stem cell transplantation
    Lim, Z. Y.
    Cook, G.
    Johnson, P. R.
    Parker, A.
    Zuckerman, M.
    Marks, D.
    Wiltshire, H.
    Mufti, G. J.
    Pagliuca, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 56 - 56
  • [25] Comparison of LightCycler-based PCR, COBAS Amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation
    Pang, XLL
    Chui, L
    Fenton, J
    LeBlanc, B
    Preiksaitis, JK
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (07) : 3167 - 3174
  • [26] The results of risk adapted pre-emptive therapy of CMV infection with ganciclovir in 169 patients, after allogeneic hematopoietic stem cell transplantation in Hematology-Oncology and BMT Research Center
    Iravani, M
    Faghih, AH
    Shamshiri, AR
    Toutounchi, M
    Tavakoli, M
    Mousavi, A
    Bahar, B
    Alimoghadam, K
    Jahani, M
    Ghavamzadeh, A
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 22 - 22
  • [27] The results of risk adapted pre-emptive therapy of CMV infection with ganciclovir in 169 patients, after allogeneic haematopoietic stem cell transplantation in haematology-oncology and BMT research centre
    Iravani, M
    Faghih, AH
    Shamshiri, AR
    Toutounchi, M
    Tavakoli, M
    Mousavi, A
    Alimoghaddam, K
    Bahar, B
    Jahani, M
    Ghavamzadeh, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S344 - S344
  • [28] Significance of qualitative PCR detection method for pre-emptive therapy of cytomegalovirus infection in patiens after allogeneic hematopoietic stem cell transplantation-single-centre experience
    Skapová, D
    Rácil, Z
    Dvoráková, D
    Minaríková, D
    Mayer, J
    JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (04) : 310 - 311
  • [29] Monitoring of CMV infection: A comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation
    Hebart, H
    Muller, C
    Loffler, J
    Jahn, G
    Einsele, H
    BONE MARROW TRANSPLANTATION, 1996, 17 (05) : 861 - 868
  • [30] An open-label randomised study of oral valganciclovir versus intravenous ganciclovir for pre-emptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation
    Volin, L.
    Barkholt, L.
    Nihtinen, A.
    Aschan, J.
    Uotinen, H.
    Haegglund, H.
    Juvonen, E.
    Ringden, O.
    Ruutu, T.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S47 - S47
1234